Sclerosis/Lupus Flashcards
white fingers caused by
blood flow cut off
blue fingers caused by
low oxygen
red fingers caused by
blood return
how much of Raynaud’s is primary
60%
indications of primary Raynauds
normal nail fold capillaries
spares the palms
how much of Raynaud’s is secondary
40%
scleroderma diagnosis
thickened skin
oral manifestations of systemic sclerosis
perioral skin tightening- decreased oral aperture
periodontal disease
telangiectasias on lips and tongue
environmental factors contributing to SS
silica exposure organic solvents industrial fumes CMV, parvo history of childbearing cancer
morpheme may indicate
abnormalities of underlying mesenchymally-derived tissues, including the skull
CREST- C
calcinosis- calcium deposits in skin
CREST- R
Raynaud’s phenomenon
CREST-E
esophageal dysfunction- acid reflex and decrease in motility of esophagus
CREST-S
sclerodactyly- thickening and tightening of skin on fingers and hands
CREST-T
telangiectasias-dilation of capillaries causing red marks on surface of skin
how long between Raynaud’s and onset of limited sclerosis
10 years
tendon friction rubs are indicative of
large joint involvement
serum markers in DSSc
anti-Scl70 (anti-topoisomerase
anti-RNA polumerase
how long between Raynaud’s and onset of diffuse sclerosis
one year
extensive skin sclerosis
proximal to the wrists, often involving trunk but sparing the back
factors favoring ischemia in secondary Raynaud’s
vasoconstriction, endothelial damage decreased NO, prostacyclin Decrease in activated VEGF active alpha-2 receptors endothelin-1 increase decreased fibronolysis
treatment of scleroderma renal disease
ACE inhibitors
SSc lung disease
pulmonary hypertension
interstitial lung disease
SSc cardiac disease
conduction system
cardiomyopathy, pericarditis…
SSc upper GI disease
GERD, esophageal dysmotility, aperistaltic esophagus, esophageal stricture
SSc lower GI manifestations
decreased peristalsis- pseudo-obstruction
bacterial overgrowth, malabsorption
megacolon
wide-mouth diverticuli
SSc musculoskeletal manifestations
arthralgia tendon friction rubs inflammatory arthritis myopathy calcinosis acrolysis
anti-centromere autoantibody
limited cutaneous disease
digital ischemia
audiovestibular disease
female predominance
anti-Scl-70
diffuse disease- interstitial lung disease
anti-RNA pol III
diffuse skin disease, renal crisis
T cells (CD4+) produce
IL4, IL6, IL13
B cells (CD20+) secrete
IL6, TGF_beta
HLA function
presentation of antigen
ITGAM function
adhesion of WBC to endothelium tolerance
IRF5 function
production of IFN alpha
BLK function
activation of B cells
abnormalities of T cells in lupus
Hyperactivation of helper cells Recognition of self antigens Autoreactive clones escape tolerance T cell repertoire skewed toward help Defective T cell regulatory circuits
abnormalities of B cells in lupus
Hyperactivation
Recognition of self antigens (RNA/protein particles
what happens to rates of apoptosis in SLE lymphocytes
increased
what happens to rate of phagocytosis in SLE
decreased
what must blebs be coated with for clearance
C1q
Belimumab
neutralizing human monoclonal antibody against BLyS
what does belimumab do
decreases B cell development, proliferation, Ig production
definite diagnosis of SLE requires how many features
4 of 11
specific autoantibodies for lupus
anti-dsDNA
anti-Sm
antiphospholipid
comorbidities of SLE
premature atherosclerosis
malar rash
Fixed erythema, flat or raised,sparing the nasolabial folds
discoid rash
Raised patches, adherent keratotic scaling, folicular plugging; older lesions may cause scarring
photosensitivity
Skin rash from sunlight by patient history or physician observation
mouth involvement in SLE
oral or naso-pharyngeal ulcers in 50-75%
usually painless
arthritis description in SLE
non-erosive, non-deforming
morning stiffness
knees, small joints of hands
cardiac criteria for SLE
pericarditis most prominent
pulmonary criteria for SLE
pleural effusion
class I LN
minimal mesangial
class II LN
mesangial proliferative
class III LN
focal
class IV LN
diffuse
class V LN
membranous
class VI LN
advanced sclerotic
diffuse proliferative LN
Extensive immune complex deposition in mesangium and subendothelial side of capillary basement membranes
Immune complex deposition confined to intramembranous and subepithelial area of capillary basement membrane
membranous lupus nephritis
neuro presentations of SLE
organic mental syndrome
seizures
what type of anemia in SLE
hemolytic most frequent
pathogenic autoantibodies in SLE
IgG
Monospecific
High affinity
Somatically mutated
anti-dsDNA
diagnostic, may correlate with disease
renal
anti-Sm
CNS involvement
anti-nRNP
joints > renal
anti-SSA/Ro, SSB/La
neonatal lupus, SS, SCLE
antiphospholipids
thrombosis
neonatal lupus 2 forms
congenital heart block, neonatal rash
complement activation results in production of what
chemotactic factor
anaphylotoxins
complement activation results in
glomerulonephritis, fetal loss
moderate disease: add what medication (SLE)
belimumab
severe disease: add what medication (SLE)
mycophenalate mofetil (MMF)